Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Actelion Ltd    ATLN   CH0010532478

ACTELION LTD (ATLN)

31
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Actelion Ltd
Develops, produces and markets pharmaceutical drugs

Actelion Ltd. is a biopharmaceutical company, which engages in the development and commercialization of drugs.

The company discovers, develops and commercializes innovative low molecular weight drugs for high unmet medical needs.

Its products are used for human therapeutics for life threatening diseases such as cardiovascular, cardiopulmonary, immunological, metabolic, and nervous system disorders.

The company was founded by by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Mueller, and Thomas Widmann on December 17, 1997 and is headquartered in Allschwil, Switzerland.
Sales per Businesses
20122013Delta
CHF (in Million)%CHF (in Million)%
Drugs1,728100%1,786100% +3.21%
Managers
NameAgeSinceTitle
Michael Jacobi, PhD612009Director
Jean-Paul Clozel, MD591997Chief Executive Officer & Director
Werner Henrich71-Director
Jean P. Malo CFA, MBA60-Director
Juhani Anttila60-Director
Carl B. Feldbaum702007Director
Marian Borovsky, LLD452000Secretary, Senior VP & Group General Counsel
Martine Clozel, MD591997Chief Scientific Officer & Senior Vice President
Otto Schwarz, PhD592008Chief Operating Officer & Executive Vice President
Walter Fischli, PhD651997Senior Vice President-Academic Relations
Shareholders
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ITI INC
ACTELION LTD
MEDIVATION INC
SHANGHAI RAAS BLO..
-
INTERCEPT PHARMAC..
NPS PHARMACEUTICA..
BEIJING SL PHARMA..
MANNKIND CORPORAT..
HUALAN BIOLOGICAL..
GENMAB A/S
TONGHUA DONGBAO P..
GW PHARMACEUTICAL..
KERYX BIOPHARMACE..
CLOVIS ONCOLOGY I..
AGIOS PHARMACEUTI..
BIOCON LTD
RECEPTOS INC
DYAX CORP.
PEPTIDREAM INC
ACORDA THERAPEUTI..
Sector Biotechnology & Medical Research
Company contact information
16 Gewerbestrasse
CH-4123 Allschwil
Switzerland

Phone : +41 61 565 65 65
Fax : +41 61 565 65 00
Internet : http://www.actelion.com
Markets and indexes
- SIX Swiss Exchange
- Main Standard
- SMI /
Stock Exchange Codes
- ISIN Code :  CH0010532478
- Bloomberg Code :  ATLN:VX
- Reuters Code :  ATLN.VX
- Datastream Code :  S:ATLN
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF